eClinicalMobile vs ASCCP Management Guidelines

eClinicalMobile® allows providers to access the system anywhere through their smart phone. The screen has been optimized for easier viewing and to load quickly on these handheld devices. Users are able to access schedules, write prescriptions, and access encounters with the peace of mind that the data is encrypted and hosted on a secure gateway. eClinicalMobile provides user name and password as part of the log-on security function. Once logged in, icons are displayed for ease of use in choosing your function. Functions include: Checking schedules Telephone and web messages e-Prescribing Viewing patient encounters Examining lab results Charge capture at the point of service eClinicalWorks® understands the daily juggling act that providers deal with trying to balance their life outside of the office. eClinicalMobile allows you to be in contact with your staff and have access to the vital information that resides on your computer without having to go into the office. The product offers access to your patients’ information with a tap of the screen enabling you to provide your patients the best care possible and in a timely manner.

The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios. ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines. These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to: • Allow for a more complete and precise estimation of risk • Provide more appropriate intervention for high-risk individuals (detect and treat more precancer) • Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm) • Allow for the future addition of new risk modifiers and screening and management technologies See https://www.asccp.org/UserGuide for tips on using the app.